Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
Authors:
- Silke KullmannSKSilke Kullmann
- Priska BinnerPBPriska Binner
- Kirsten RackebrandtKRKirsten Rackebrandt
- Andreas HugeAHAndreas Huge
- Georg HalternGHGeorg Haltern
- Mark LankischMLMark Lankisch
- Reiner FüthRFReiner Füth
- Eberhard von HodenbergEHEberhard von Hodenberg
- Hans-Peter BestehornHBHans-Peter Bestehorn
- Thomas ScheffoldTSThomas Scheffold
Open Access
- 8 October 2009
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 9 (1) , 48
Abstract
Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether the EPHX2 K55R polymorphism, previously linked to significantly higher risk for coronary heart disease (CHD), was associated with the occurrence of restenosis after PCI. The association with incident CHD should have been confirmed and a potential correlation of the EPHX2 K55R variant to an increased risk of hypertension was analysed.Keywords
This publication has 36 references indexed in Scilit:
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variantsNature Genetics, 2009
- Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive RatHypertension, 2008
- Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart StudyDiabetes & Vascular Disease Research, 2008
- Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted MiceJournal of Biological Chemistry, 2007
- Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) studyHuman Molecular Genetics, 2006
- Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vesselsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Genetic predictive factors in restenosisPathologie Biologie, 2004
- Novel approaches for the prevention of restenosisExpert Opinion on Investigational Drugs, 2000
- Identification and Functional Characterization of Human Soluble Epoxide Hydrolase Genetic PolymorphismsJournal of Biological Chemistry, 2000
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988